0358 GMT - TPG Telecom's bull at Macquarie see an increasing chance that the Australian mobile operator engages in capital management. With an unchanged outperform rating on the stock, an analyst at the investment bank calls clients' attention to TPG's surprise dividend hike and reiteration of its policy to sustainably grow its twice-yearly payout. Supporting this view, a note from the analyst points to limited capital expenditure commitments until spectrum payments in FY 2028, and its debt refinancing. TPG's free cash-flow profile and growth are improving, the analyst adds. Macquarie lifts its target price 2.5% to 4.10 Australian dollars. Shares are up 0.4% at A$3.825. (stuart.condie@wsj.com)

0352 GMT - WiseTech's bull at Citi sees signs that the logistics-software provider's redundancy program may be running more slowly than anticipated. Analyst Siraj Ahmed says an analysis of LinkedIn suggests that Australia-listed WiseTech reduced its headcount by 885 since January. He points out in a note that this is lower than WiseTech's target of 2,000, and tells clients that it compares with his assumption that the company's fiscal 2027 accounts will include expenditure on 1,700 redundancies. That said, Ahmed acknowledges that people might not be quick to update their LinkedIn profile after being made redundant. Citi has a last-published buy rating on the stock and a target price of 55.05 Australian dollars. Shares are 2.7% higher at A$43.47. (stuart.condie@wsj.com)

2352 GMT - Shares of fuel refiner and marketer Ampol should trade well today, says Jefferies. That's because Ampol's 1H result was even better than its initial announcement at end-July. Ampol reported Ebit of A$1.39 billion, above the A$1.35 billion signaled weeks earlier. Analyst Michael Simotas says an interim dividend of A$1.85/share is better than expected. He also likes double-digit Convenience Retail Ebit growth in 1H and persistent strength in refining. "Recent retail fuel margin weakness called out by Ampol is readily observable from market data and we agree with management that it's temporary," Jefferies says. Key questions for investors include whether there has been a structural lift in wholesale margins and the outlook for shareholder distributions, it says. Ampol ended last week at A$39.85. (david.winning@wsj.com; @dwinningWSJ)

2349 GMT - PLS's stronger-than-anticipated dividend is partly offset by slightly softer-than-expected net profit and earnings per share, says Citi. It says PLS's Ngungaju ramp-up and P2000 project are now the focus for investors. "P2000 feasibility study outcomes remain due in the December quarter, with A$175 million of pre-FID [final investment decision] expenditure included in FY27 guidance but potential post-FID capital excluded," Citi says. It reiterates a buy rating and A$5.00 target. Shares ended Friday at A$5.07. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

2342 GMT - NIB's share price could weaken today, says Citi. That's because NIB's Australian residents health insurance business disappointed in FY26. NIB reported soft margins within its arhi business. NIB guides to a stable annual underlying net margin of 6-7%. It also projects policyholder growth of 1.9%. "We note the moderation in growth and elevated lapse rates of 16.2% could be in part due to its repositioning to higher value silver customers," analyst Nigel Pittaway says. "However, it also likely reflects industry trends and is something nib will need to focus on moving forward." Citi expects the market to place more weight on the arhi disappointment than a recovery in New Zealand, core EPS beat and A$0.05/share special dividend. "We wouldn't be surprised to see the stock trade flat to down today," Citi says. (david.winning@wsj.com; @dwinningWSJ)

2333 GMT - Barrenjoey expects drinks-to-hotel group Endeavour's share price to fall today, despite very strong trading in its retail division recently. Analyst Tom Kierath says guidance on annual costs is higher than consensus expectations. Endeavour signaled FY27 finance costs of A$330 million-A$340 million, above market hopes for A$328 million. Forecasts of A$50 million-A$55 million operating expenses tied to its One Endeavour program is above prior guidance of A$50 million. "An additional A$40 million-A$60 million of opex is expected in FY27 to support transformational initiatives, which looks incremental versus strategy day comments," Barrenjoey says. Still, it's upbeat about recent trading. Endeavour said Retail sales, which includes Dan Murphy's and BWS, rose by 4.6% in the first seven weeks of FY27. Tha's versus consensus expectations for FY27 of 1.6%. (david.winning@wsj.com; @dwinningWSJ)

2331 GMT - Ansell's bull at RBC sees scope for the stock to continue its recent outperformance on the personal-protective equipment maker's earnings beat and strong outlook. Analyst Craig Wong-Pan, who has a last-published outperform rating on the stock, tells clients in a note that FY 2026 underlying profit beat consensus by 4%. The midpoint of Ansell's FY 2027 EPS guidance is an even stronger beat, sitting 7% ahead at the range midpoint. Wong-Pan highlights good June-half revenue growth across both industrial and healthcare, but notes a A$15 million benefit from customer restocking of exam/single-use gloves. RBC has a target price of 36.00 Australian dollars on the stock, which is at A$34.90 ahead of the open. (stuart.condie@wsj.com)

2319 GMT - The reinstatement of dividends by PLS should be taken positively by the market, Barrenjoey says in a client note. The A$0.05/share dividend is a strong beat versus consensus of A$0.03/share, says the bank. It has an overweight rating and A$6.00 share-price target on PLS. In a separate note, RBC Capital Markets also cheers the payout. It is the company's first dividend since FY24, RBC says. "The dividend represents a 22% payout of FY26 adjusted free cash flow, within PLS' target dividend payout ratio of 20-30% of free cash flow," says the broker. It has an outperform rating and A$5.50 target on the stock. Shares ended Friday at A$5.07. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

2303 GMT - Ansell's apparent success in offsetting the margin impacts of inflation shows the business is in better shape than two or three years ago, Citi analyst Laura Sutcliffe says. Sutcliffe, who has a last-published neutral rating on the stock, tells clients in a note that the personal-protective equipment maker appears to have mitigated the effects of raw-material price volatility related to the U.S.-Iran conflict. She thinks Ansell has passed through price increases to its customers in a timely fashion, which she points out wasn't the case when inflation hit costs a few years ago. Sutcliffe expects a positive response to Ansell's stronger-than-expected earnings guidance. Citi has a last-published target price of A$33.50 on the stock, which is at A$34.90 ahead of the open. (stuart.condie@wsj.com)

2256 GMT - Ansell's healthcare margins are seen at Jefferies as the driver of the Australia-listed company's earnings beat. Analyst Vanessa Thomson, who has a last-published buy rating on the stock, tells clients in a note that the personal-protective equipment maker benefited from sales of its higher-margin cleanroom gloves. She adds that the bottom end of Ansell's FY27 earnings-per-share guidance range is higher than both her forecast and consensus hopes. Jefferies has a last-published target price of A$38.20. Shares are at A$34.90 ahead of the open.